Last update 20 Mar 2025

RGT-264

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target
HPK1
Action
inhibitors
Mechanism
HPK1 inhibitors(Mitogen-activated protein kinase kinase kinase kinase 1 inhibitors)
Therapeutic Areas
Neoplasms
Active Indication
Neoplasms
Inactive Indication
Advanced Malignant Solid Neoplasm
Originator Organization
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
Active Organization
Regor Therapeutics GroupRegor Therapeutics GroupStartup
Inactive Organization
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with RGT-264
NCT05764915
/ TerminatedPhase 1
A Phase I Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of RGT-264 Phosphate Tablets in Subjects With Advanced Solid Tumors
100 Clinical Results associated with RGT-264
Login to view more data
100 Translational Medicine associated with RGT-264
Login to view more data
100 Patents (Medical) associated with RGT-264
Login to view more data
100 Deals associated with RGT-264
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
NeoplasmsPhase 1
China
Regor Therapeutics GroupRegor Therapeutics GroupStartup
26 Apr 2023
Advanced Malignant Solid NeoplasmPreclinical
China
Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.Shanghai Qilu Ruige Pharmaceutical R&D Co., Ltd.
15 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free